Literature DB >> 8793241

Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy.

M Goicoechea, F Gomez-Campdera, J R Polo, A Tejedor, M A Ruiz, I Vazquez, E Verde, F Valderrabano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8793241

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN： 0301-0430            Impact factor:   0.975


× No keyword cloud information.
  4 in total

1.  A patient undergoing chronic dialysis whose renal anemia was successfully corrected by treatment with cinacalcet.

Authors:  Yoshiyuki Oshiro; Hisataka Tanaka; Niro Okimoto
Journal:  Clin Exp Nephrol       Date:  2011-04-01       Impact factor: 2.801

Review 2.  Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

3.  Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease.

Authors:  Domenico Russo; Luigi Morrone; Biagio Di Iorio; Michele Andreucci; Maria Grazia De Gregorio; Carmela Errichiello; Luigi Russo; Francesco Locatelli
Journal:  J Nephrol       Date:  2014-08-12       Impact factor: 3.902

4.  Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis.

Authors:  Piyatida Chuengsaman; Surapong Narenpitak; Suchai Sritippayawan
Journal:  World J Nephrol       Date:  2021-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.